These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 7570465

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Epidemiologic studies of beta agonists and asthma deaths.
    Pearce N, Hensley MJ.
    Epidemiol Rev; 1998; 20(2):173-86. PubMed ID: 9919437
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992.
    Lanes SF, Birmann B, Raiford D, Walker AM.
    J Clin Epidemiol; 1997 Mar; 50(3):321-8. PubMed ID: 9120532
    [Abstract] [Full Text] [Related]

  • 6. The use of beta agonists and the risk of death and near death from asthma.
    Pearce N.
    J Clin Epidemiol; 2009 Jun; 62(6):582-7. PubMed ID: 19422997
    [No Abstract] [Full Text] [Related]

  • 7. Beta agonists and asthma mortality: déjà vu.
    Pearce N, Crane J, Burgess C, Jackson R, Beasley R.
    Clin Exp Allergy; 1991 Jul; 21(4):401-10. PubMed ID: 1680532
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic.
    Beasley R, Pearce N, Crane J, Burgess C.
    Int Arch Allergy Immunol; 1995 Jul; 107(1-3):325-7. PubMed ID: 7613161
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Risk of severe life threatening asthma.
    Barnes NC, Kuitert LM.
    Thorax; 1996 Nov; 51(11):1073. PubMed ID: 8958886
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Beta 2-agonists and New Zealand asthma mortality.
    Burgess C, Crane J, Pearce N, Beasley R.
    Lancet; 1991 Apr 20; 337(8747):982-3. PubMed ID: 1678066
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.
    Sears MR, Taylor DR.
    Drug Saf; 1994 Oct 20; 11(4):259-83. PubMed ID: 7848546
    [Abstract] [Full Text] [Related]

  • 18. The use of beta-agonists and the risk of death and near death from asthma.
    Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, McNutt M, Buist AS, Rebuck AS.
    N Engl J Med; 1992 Feb 20; 326(8):501-6. PubMed ID: 1346340
    [Abstract] [Full Text] [Related]

  • 19. The proper role of beta 2-adrenergic agonists in the treatment of children with asthma.
    Furukawa CT, Kemp JP, Simons FE, Tinkelman DG.
    Pediatrics; 1992 Oct 20; 90(4):639-40. PubMed ID: 1357623
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.